Repurposing metabolic drugs for COVID-19

被引：0
|
作者：
Yvonne Bordon
机构：
[1] Nature Reviews Immunology,
来源：
Nature Reviews Immunology | 2023年 / 23卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：203 / 203
相关论文
共 50 条
  • [31] Repurposing Approved Drugs for Guiding COVID-19 Prophylaxis: A Systematic Review
    Andrade, Bruno Silva
    Rangel, Fernanda de Souza
    Santos, Naiane Oliveira
    Freitas, Andria dos Santos
    de Assis Soares, Wagner Rodrigues
    Siqueira, Sergio
    Barh, Debmalya
    Goes-Neto, Aristoteles
    Birbrair, Alexander
    de Carvalho Azevedo, Vasco Ariston
    [J]. FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [32] COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs
    Tufan, Abdurrahman
    Avanoglu Guler, Aslihan
    Matucci-Cerinic, Marco
    [J]. TURKISH JOURNAL OF MEDICAL SCIENCES, 2020, 50 : 620 - 632
  • [33] A pharmacometric approach to evaluate drugs for potential repurposing as COVID-19 therapeutics
    Wattanakul, Thanaporn
    Chotsiri, Palang
    Scandale, Ivan
    Hoglund, Richard M.
    Tarning, Joel
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15 (08) : 945 - 958
  • [34] Repurposing of known drugs for COVID-19 using molecular docking and simulation analysis
    Bhanu, Piyush
    Setlur, Anagha S.
    Chandrashekar, K.
    Niranjan, Vidya
    Kumar, Nisha Hemandhar
    Buchke, Sakshi
    Kumar, Jitendra
    Rani, Anita
    Tiwari, Sushil M.
    Mishra, Vachaspati
    [J]. BIOINFORMATION, 2023, 19 (02) : 149 - 159
  • [35] A review on drug repurposing in COVID-19: from antiviral drugs to herbal alternatives
    Abas Sezer
    Mervisa Halilović-Alihodžić
    Annissa Rachel Vanwieren
    Adna Smajkan
    Amina Karić
    Husein Djedović
    Jasmin Šutković
    [J]. Journal of Genetic Engineering and Biotechnology, 20
  • [36] Existing highly accumulating lysosomotropic drugs with potential for repurposing to target COVID-19
    Norinder, Ulf
    Tuck, Astrud
    Norgren, Kalle
    Kos, Vesna Munic
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2020, 130
  • [37] Repurposing Drugs for the Management of Patients with Confirmed Coronavirus Disease 2019 (COVID-19)
    Wietzikoski Lovato, Evellyn Claudia
    Barboza, Lorena Neris
    Wietzikoski, Samantha
    Vasques de Souza, Amanda Nascimento
    Auth, Pablo Alvarez
    Gasparotto Junior, Arquimedes
    dos Reis Livero, Francislaine Aparecida
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (01) : 115 - 126
  • [38] Transcriptomic signatures and repurposing drugs for COVID-19 patients: findings of bioinformatics analyses
    Li, Guobing
    Ruan, Shasha
    Zhao, Xiaolu
    Liu, Qi
    Dou, Yali
    Mao, Fengbiao
    [J]. COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2021, 19 : 1 - 15
  • [39] A review on drug repurposing in COVID-19: from antiviral drugs to herbal alternatives
    Sezer, Abas
    Halilovic-Alihodzic, Mervisa
    Vanwieren, Annissa Rachel
    Smajkan, Adna
    Karic, Amina
    Djedovic, Husein
    Sutkovic, Jasmin
    [J]. JOURNAL OF GENETIC ENGINEERING AND BIOTECHNOLOGY, 2022, 20 (01)
  • [40] Repurposing of Anticancer Drugs Expands Possibilities for Antiviral and AntiInflammatory Discovery in COVID-19
    Aldea, Mihaela
    Michot, Jean-Marie
    Danlos, Francois-Xavier
    Ribas, Antoni
    Soria, Jean-Charles
    [J]. CANCER DISCOVERY, 2021, 11 (06) : 1336 - 1344
12345